CCO Oncology Podcast

Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes

Episode Summary

Join Dr. Amy DeZern, Dr. Daniel Pollyea, and Dr. Amer Zeidan as they discuss their treatment strategies for 3 patients with myelodysplastic syndromes.

Episode Notes

In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, including

• Treatment for MDS after ESA failure
• Strategies for patients with intermediate- or high-risk MDS
• Luspatercept therapy in MDS
• MDS case challenges

Link to full program, including downloadable slidesets:
https://bit.ly/3tYwcYu

Presenters: 
Amy E. DeZern, MD, MHS
Associate Professor
Oncology and Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Daniel Pollyea, MD, MS
Associate Professor of Medicine
Clinical Director of Leukemia Services
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Amer Zeidan, MBBS
Associate Professor, Internal Medicine
Hematology
Yale University
New Haven, Connecticut